Literature DB >> 16142339

Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.

Ling Yu1, Hisanori Takenobu, Osamu Shimozato, Kiyoko Kawamura, Yoshinori Nimura, Naohiko Seki, Katsuhiro Uzawa, Hideki Tanzawa, Hideaki Shimada, Takenori Ochiai, Masatoshi Tagawa.   

Abstract

Esophageal and oral carcinomas are relatively resistant to adenovirus serotype 5 (Ad5)-mediated gene transfer, primarily because expression of the cellular receptors for Ad5, the coxsackievirus and adenovirus receptor, is often downregulated in these types of tumor. The types of Ad in which the receptor expression is not suppressed in tumors are therefore better vectors for gene transfer into tumors. CD46, a cellular receptor for Ad subtype B2, such as Ad11 and Ad35, is well expressed in a number of esophageal and oral tumor cells. Since the infectivity of Ad to target cells is mainly influenced by the interaction between their fibers and the cellular receptors, we examined the infectivity of chimeric Ad5, whose fiber structure was substituted with that of type 11 or 35 (Ad5/11 or Ad5/35), to 6 human oral and 11 esophagus carcinoma cells. We found that the chimeric Ad, in particular Ad5/35, infected more effectively than Ad5 in all the tumors tested. However, the efficacy of Ad5/35- and Ad5/11-mediated transduction was not correlated with the expression level of CD46 or CD80/86, a cellular receptor of the Ad subtype B1, in the target cells. These data suggest that the Ad subtype B2 are suitable vectors of gene transfer for human squamous cell carcinomas of the upper gastrointestinal tract, and that the infectivity of the Ad subtype B2 can possibly be regulated by other receptors besides CD46.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142339

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.

Authors:  Guangyu Ma; Boya Zhong; Shinya Okamoto; Yuanyuan Jiang; Kiyoko Kawamura; Hongdan Liu; Quanhai Li; Masato Shingyoji; Ikuo Sekine; Yuji Tada; Koichiro Tatsumi; Hideaki Shimada; Kenzo Hiroshima; Masatoshi Tagawa
Journal:  Tumour Biol       Date:  2015-05-20

Review 2.  A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.

Authors:  Ming Yang; Chun Sheng Yang; WenWen Guo; JianQin Tang; Qian Huang; ShouXin Feng; AiJun Jiang; XiFeng Xu; Guan Jiang; Yan Qun Liu
Journal:  Cancer Biol Ther       Date:  2017-11-16       Impact factor: 4.742

3.  Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins.

Authors:  Bishnu Acharya; Shuji Terao; Toru Suzuki; Michio Naoe; Katsuyuki Hamada; Hiroyuki Mizuguchi; Akinobu Gotoh
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

4.  Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.

Authors:  Youguang Zhao; Ying Li; Qingtang Wang; Liang Wang; Hang Yang; Mingli Li
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

5.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

6.  Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.

Authors:  M Takagi-Kimura; T Yamano; M Tagawa; S Kubo
Journal:  Cancer Gene Ther       Date:  2014-02-28       Impact factor: 5.987

7.  Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.

Authors:  Y Takei; S Okamoto; K Kawamura; Y Jiang; T Morinaga; M Shingyoji; I Sekine; S Kubo; Y Tada; K Tatsumi; H Shimada; K Hiroshima; N Yamaguchi; M Tagawa
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

8.  Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.

Authors:  Misato Takagi-Kimura; Tomoki Yamano; Atsuko Tamamoto; Nobutaka Okamura; Haruki Okamura; Tomoko Hashimoto-Tamaoki; Masatoshi Tagawa; Noriyuki Kasahara; Shuji Kubo
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

9.  Serotype chimeric human adenoviruses for cancer gene therapy.

Authors:  Tuuli Ranki; Akseli Hemminki
Journal:  Viruses       Date:  2010-09-30       Impact factor: 5.818

10.  Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects.

Authors:  Q Li; K Kawamura; S Okamoto; H Fujie; M Numasaki; M Namba; M Nagata; H Shimada; H Kobayashi; M Tagawa
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.